CHEMISTRY TOOLSCHEM TOOLS
ElementsCompoundsToolsBiologyMedicineReference
⌘K
All CompoundsAmino AcidsBiochemicalsInorganic
Periodic Table/Compounds/CHEMBL406517

Elements

  • Periodic Table
  • Trends
  • Compare
  • Nuclides

Compounds

  • All Compounds
  • Amino Acids
  • Biochemicals
  • Inorganic

Tools

  • All Tools
  • Molar Mass
  • Electron Config
  • Decay Simulator
  • Balancer
  • Stoichiometry
  • Gas Laws
  • Solutions
  • Equilibrium
  • Kinetics
  • Oxidation States
  • Acid-Base
  • Solubility
  • Electrochemistry
  • Thermodynamics
  • Reactions
  • Spectroscopy
  • Orbitals
  • Lewis Structure
  • VSEPR
  • Nomenclature
  • Unit Converter

Biology

  • Biological Roles
  • Amino Acids
  • Metabolic Pathways
  • Nucleotides
  • Metals in Biology

Medicine

  • Drug Index
  • Drug Mechanisms
  • Radiopharmaceuticals
  • Toxicology
  • Therapeutic Elements

Reference

  • Glossary
  • Constants
  • Polyatomic Ions
  • Activity Series
  • Solubility Rules
  • Lab Safety
© Melvin Olsson 2025–2026
Data: IAEA & PubChem

CHEMBL406517

C₃₇H₆₇NO₁₃·733.900 g/mol·CID 10897911

IUPAC: (6R,7S,9R,11R,12R,13S)-6-[(3R)-4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy-14-ethyl-7,12,13-trihydroxy-4-[(2R,4R,5S)-5-hydroxy-4-methoxy-4,6-dimethyloxan-2-yl]oxy-3,5,7,9,11,13-hexamethyl-oxacyclotetradecane-2,10-dione

Also known as: BDBM50421353

2D structure of CHEMBL406517

Molecular Structure

Molecular Propertiesmass · H-bonds · stereo

Molecular Weight

733.900g/mol

Exact Mass

733.461241Da

Monoisotopic Mass

733.461241Da

XLogP

2.7

Polar Surface Area

194.0Ų

Complexity

1180

Formal Charge

0

H-Bond Donors

5

H-Bond Acceptors

14

Rotatable Bonds

7

Heavy Atoms

51

Stereo Centers

10

Bond Stereo

0

Drug-Likeness (Lipinski's Rule of Five)

✗ 733.9 g/mol
MW ≤ 500
✓ 2.7
LogP ≤ 5
✓ 5
H-bond donors ≤ 5
✗ 14
H-bond acceptors ≤ 10

2 violations — poor oral bioavailability predicted

Chemical IdentifiersSMILES · InChI

InChI

InChI=1S/C37H67NO13/c1-14-25-37(10,45)30(41)20(4)27(39)18(2)16-35(8,44)32(51-34-28(40)24(38(11)12)15-19(3)47-34)21(5)29(22(6)33(43)49-25)50-26-17-36(9,46-13)31(42)23(7)48-26/h18-26,28-32,34,40-42,44-45H,14-17H2,1-13H3/t18-,19?,20+,21?,22?,23?,24?,25?,26+,28-,29?,30-,31+,32-,34?,35+,36-,37-/m1/s1

Isomers8 compounds with formula C₃₇H₆₇NO₁₃

2D structure of (3R,4S,5S,6R,7R,9R,11R,12R,13S,14R)-6-[(2S,3R,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy-14-ethyl-7,12,13-trihydroxy-4-[(2R,4R,5S,6S)-5-hydroxy-4-methoxy-4,6-dimethyloxan-2-yl]oxy-3,5,7,9,11,13-hexamethyl-oxacyclotetradecane-2,10-dione

(3R,4S,5S,6R,7R,9R,11R,12R,13S,14R)-6-[(2S,3R,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy-14-ethyl-7,12,13-trihydroxy-4-[(2R,4R,5S,6S)-5-hydroxy-4-methoxy-4,6-dimethyloxan-2-yl]oxy-3,5,7,9,11,13-hexamethyl-oxacyclotetradecane-2,10-dione

CID 12560 · 733.9 g/mol

2D structure of (3R,4S,5S,6R,7R,9R,11R,12R,13S,14R)-14-ethyl-12,13-dihydroxy-4-[(2R,4R,5S,6S)-5-hydroxy-4-methoxy-4,6-dimethyloxan-2-yl]oxy-6-[(2S,3R,4S,6R)-3-hydroxy-6-methyl-4-(methylamino)oxan-2-yl]oxy-7-methoxy-3,5,7,9,11,13-hexamethyl-oxacyclotetradecane-2,10-dione

(3R,4S,5S,6R,7R,9R,11R,12R,13S,14R)-14-ethyl-12,13-dihydroxy-4-[(2R,4R,5S,6S)-5-hydroxy-4-methoxy-4,6-dimethyloxan-2-yl]oxy-6-[(2S,3R,4S,6R)-3-hydroxy-6-methyl-4-(methylamino)oxan-2-yl]oxy-7-methoxy-3,5,7,9,11,13-hexamethyl-oxacyclotetradecane-2,10-dione

CID 11072636 · 733.9 g/mol

2D structure of 6-[4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy-14-ethyl-7,12,13-trihydroxy-4-(5-hydroxy-4-methoxy-4,6-dimethyloxan-2-yl)oxy-3,5,7,9,11,13-hexamethyl-oxacyclotetradecane-2,10-dione

6-[4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy-14-ethyl-7,12,13-trihydroxy-4-(5-hydroxy-4-methoxy-4,6-dimethyloxan-2-yl)oxy-3,5,7,9,11,13-hexamethyl-oxacyclotetradecane-2,10-dione

CID 3255 · 733.9 g/mol

2D structure of 14-ethyl-12,13-dihydroxy-4-(5-hydroxy-4-methoxy-4,6-dimethyloxan-2-yl)oxy-6-[3-hydroxy-6-methyl-4-(methylamino)oxan-2-yl]oxy-7-methoxy-3,5,7,9,11,13-hexamethyl-oxacyclotetradecane-2,10-dione

14-ethyl-12,13-dihydroxy-4-(5-hydroxy-4-methoxy-4,6-dimethyloxan-2-yl)oxy-6-[3-hydroxy-6-methyl-4-(methylamino)oxan-2-yl]oxy-7-methoxy-3,5,7,9,11,13-hexamethyl-oxacyclotetradecane-2,10-dione

CID 13923912 · 733.9 g/mol

2D structure of (4S,6R,7S,11S,13S)-6-[(2S)-4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy-14-ethyl-7,12,13-trihydroxy-4-[(2R,4R)-5-hydroxy-4-methoxy-4,6-dimethyloxan-2-yl]oxy-3,5,7,9,11,13-hexamethyl-oxacyclotetradecane-2,10-dione

(4S,6R,7S,11S,13S)-6-[(2S)-4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy-14-ethyl-7,12,13-trihydroxy-4-[(2R,4R)-5-hydroxy-4-methoxy-4,6-dimethyloxan-2-yl]oxy-3,5,7,9,11,13-hexamethyl-oxacyclotetradecane-2,10-dione

CID 16757675 · 733.9 g/mol

2D structure of (3R,4S,5S,6R,7R,9R,11R,12R,13S,14R)-6-[(2S,3S,4R,6S)-4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy-14-ethyl-7,12,13-trihydroxy-4-[(2R,4S,5R,6R)-5-hydroxy-4-methoxy-4,6-dimethyloxan-2-yl]oxy-3,5,7,9,11,13-hexamethyl-oxacyclotetradecane-2,10-dione

(3R,4S,5S,6R,7R,9R,11R,12R,13S,14R)-6-[(2S,3S,4R,6S)-4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy-14-ethyl-7,12,13-trihydroxy-4-[(2R,4S,5R,6R)-5-hydroxy-4-methoxy-4,6-dimethyloxan-2-yl]oxy-3,5,7,9,11,13-hexamethyl-oxacyclotetradecane-2,10-dione

CID 44451949 · 733.9 g/mol

2D structure of (3R,4S,5S,6R,7R,9R,11R,12R,13S,14R)-6-[(2R,3S,4R,6S)-4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy-14-ethyl-7,12,13-trihydroxy-4-[(2R,4R,5S,6S)-5-hydroxy-4-methoxy-4,6-dimethyloxan-2-yl]oxy-3,5,7,9,11,13-hexamethyl-oxacyclotetradecane-2,10-dione

(3R,4S,5S,6R,7R,9R,11R,12R,13S,14R)-6-[(2R,3S,4R,6S)-4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy-14-ethyl-7,12,13-trihydroxy-4-[(2R,4R,5S,6S)-5-hydroxy-4-methoxy-4,6-dimethyloxan-2-yl]oxy-3,5,7,9,11,13-hexamethyl-oxacyclotetradecane-2,10-dione

CID 8233 · 733.9 g/mol

2D structure of (3R,4R,5S,6S,7R,9S,11R,12S,13S,14S)-6-[(2S,3S,4R,6S)-4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy-14-ethyl-7,12,13-trihydroxy-4-[(2S,4S,5R,6S)-5-hydroxy-4-methoxy-4,6-dimethyloxan-2-yl]oxy-3,5,7,9,11,13-hexamethyl-oxacyclotetradecane-2,10-dione

(3R,4R,5S,6S,7R,9S,11R,12S,13S,14S)-6-[(2S,3S,4R,6S)-4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy-14-ethyl-7,12,13-trihydroxy-4-[(2S,4S,5R,6S)-5-hydroxy-4-methoxy-4,6-dimethyloxan-2-yl]oxy-3,5,7,9,11,13-hexamethyl-oxacyclotetradecane-2,10-dione

CID 6604221 · 733.9 g/mol

External Resources

PubChem ↗Wikipedia ↗